DOI: 10.1128/AAC.02548-19
Article Information
PubMed
Published By
History
- Received December 20, 2019
- Returned for modification January 24, 2020
- Accepted February 6, 2020
- Published online April 21, 2020.
Copyright & Usage
Copyright © 2020 American Society for Microbiology. All Rights Reserved.
Article Versions
- Accepted Manuscript version (February 10, 2020).
- You are viewing the most recent version of this article.
Author Information
- Clément Raynauda,
- Wassim Dahera,
- Françoise Roquet-Banèresa,
- Matt D. Johansena,
- Jozef Stecc,
- Oluseye K. Onajoled,
- Diane Ordwaye,
- Alan P. Kozikowskif and
- Laurent Kremera,b
- aCentre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France
- bINSERM, IRIM, Montpellier, France
- cDepartment of Pharmaceutical Sciences, College of Pharmacy, Marshall B. Ketchum University, Fullerton, California, USA
- dDepartment of Biological, Physical and Health Sciences, Roosevelt University, Chicago, Illinois, USA
- eColorado State University, Department of Microbiology, Immunology & Pathology, Mycobacteria Research Laboratory, Fort Collins, Colorado, USA
- fStarWise Therapeutics LLC, Chicago, Illinois, USA
- Address correspondence to Laurent Kremer, laurent.kremer{at}irim.cnrs.fr.
Citation Raynaud C, Daher W, Roquet-Banères F, Johansen MD, Stec J, Onajole OK, Ordway D, Kozikowski AP, Kremer L. 2020. Synergistic interactions of indole-2-carboxamides and β-lactam antibiotics against Mycobacterium abscessus. Antimicrob Agents Chemother 64:e02548-19. https://doi.org/10.1128/AAC.02548-19.
